Bangshun Pharmaceutical is an innovative drug research and development company, focusing on molecular targeting and antibody drug development in tumor, autoimmunity, and inflammation fields. Guided by clinical needs, it seeks differentiated development and has deployed more than ten innovative drugs The pipeline, among which, several key varieties and indications have entered the key registration clinical and phase II clinical stages. Recently, Bangshun Pharmaceutical completed the B round of financing, and this round of financing was led by Shenzhen Venture Capital.
This article is transferred from: https://www.itjuzi.com/investevent/13762784
This site is only for collection, and the copyright belongs to the original author.